MedTrace Logo

Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19

NCT04381819 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-05-11

No results posted yet for this study

Summary

Oslo University Hospital has initiated an observational study on hospitalised patients with confirmed COVID-19, the infection caused by Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2).

Conditions

  • SARS Virus
  • Severe Acute Respiratory Syndrome

Interventions

DIAGNOSTIC_TEST

SARS-CoV-2 PCR

SARS-CoV-2 E gene

Sponsors & Collaborators

  • University Hospital, Akershus

    collaborator OTHER

  • Vestre Viken Hospital Trust

    collaborator OTHER

  • Ostfold Hospital Trust

    collaborator OTHER

  • Haukeland University Hospital

    collaborator OTHER

  • University Hospital of North Norway

    collaborator OTHER

  • St. Olavs Hospital

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Fredrik G Müller, Professor · University of Oslo

  • Susanne G Dudman, Professor · University of Oslo

  • Jan C Holter, PhD · Oslo University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-02
Primary Completion
2022-02-28
Completion
2023-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04381819 on ClinicalTrials.gov